NEW YORK (GenomeWeb) – Epigenomics today reported a 15 percent year-over-year increase in its first quarter revenues as product revenues were up 32 percent.

The German-American molecular diagnostics company said that for the three months ended March 31, revenues rose to €407,000 ($559,000) from €355,000. Product revenues increased to €215,000 from €163,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: human cytomegalovirus diversity, patterns of homologous recombination in E. coli, and more.

US lawmakers are considering eliminating the medical devices tax that is part of the Affordable Care Act.

Two research teams in China home in on a gene that gives rice a long, slender shape.

Marcia McNutt, the editor-in-chief of Science, has been nominated to become president of the US National Academy of Sciences.